Laser in situ keratomileusis for residual myopia after photorefractive keratectomy

PURPOSE: To evaluate the efficacy and safety of laser in situ keratomileusis (LASIK) for myopic regression and undercorrection after photorefractive keratectomy (PRK). SETTING: The Eye Institute, Sydney, Australia. METHODS: Fifty eyes of 32 patients were treated by LASIK for residual myopia following primary PRK. The mean spherical equivalent refraction (SEQ) was -2.92 diopters (D) +/- 1.57 (SD) (range -0.75 to -7.88 D). The mean refractive cylinder was 0.96 +/- 0.74 D (range 0 to 3.50 D). For analysis, the eyes were divided into 2 groups: those with 0 or low corneal haze (Group 1) and those with severe corneal haze (Group 2). In Group 1, the SEQ was -1.99 +/- 0.79 D (range -0.75 to -3.75 D) and in Group 2, -3.77 +/- 1.62 D (range -0.75 to -7.90 D). The procedure was performed using the Chiron Automated Corneal Shaper and the Summit Apex Plus laser. The mean interval between PRK and LASIK was 25 months (range 9 to 59 months). The following parameters were studied before and after LASIK retreatment: SEQ, mean refractive cylinder, uncorrected visual acuity (UCVA), and best corrected visual acuity (BCVA). Complications after LASIK retreatment were evaluated. RESULTS: Six months after LASIK, the mean SEQ in all eyes was -0.65 +/- 0.86 D (range +1.50 to -3.35 D); 70.0% of eyes were within +/-1.00 D of emmetropia and the UCVA was 6/12 or better in 72.5%. The mean SEQ in Group 1 was -0.22 +/- 0.55 D (range -0.88 to -1.50 D) and in Group 2, -0.97+/- 0.92 D (range 0.12 to -3.25 D); the UCVA was 6/12 or better in 94.0% of eyes in Group 1 and in 56.0% in Group 2. No statistically significant between-group difference was found in lines of Snellen acuity lost or gained at 6 months. No eye lost more than 1 line of BCVA. CONCLUSIONS: Laser in situ keratomileusis appears to be a safe, effective, and predictable procedure for treating eyes with 0 or low haze with residual myopia after PRK. It is less predictable in eyes with severe haze.     

VISX S4准分子激光不同角膜切削模式联合LASIK治疗超高度近视的研究

目的 探讨V1SX S4准分子激光不同角膜切削模式联合LASIK治疗超高度近视的临床效果。方法 临床回顾性对照分析研究。选择2005年11月至2006年12月在120例（216只眼）超高度近视LASIK矫正,运用VISX S4准分子激光,根据不同的切削模式联合分为ESB组(M Ellipse+M Sphere+M Blend)74眼、ART( Advanced Refractive Treatment)组(M Ellipse-APA+M Sphere Zone1-APA+M Sphere Zone2-APA )70眼、ESS组(M Ellipse+ Multizone M Sphere Zonel+ Multizone M Sphere Zone2)组72眼,分析各组的角膜切削、术后视力与屈光以及并发症。结果 (1)角膜平面屈光改变等效球镜ID,ESB组需切削角膜（13.32±1.42）μm,ART组切削角膜(7.66±1.10)μm,ESS模式组切削角膜(12.27±0.48)μm。(2)随访1年,术后裸眼视力均较术前提高,术后1个月内均达到术前最佳矫正视力或以上;术后3个月视力趋于稳定;术后最佳矫正视力均无丢失两行以上;术后3个月屈光等效球镜均在±0.50 D内。(3)术后眩光发生率：ESB组2只眼(2.7％),ART组4只眼(5.7％),ESS组2只眼(2.8％),均在术后6个月后缓解;术后角膜地形图分析均未发现偏中心切削;术后3个月屈光回退率：ESB组3只眼(4.1％),ART组3只眼(4.3％),ESS组2只眼(2.7％)。结论 VISX S4准分子激光能根据不同的屈光度与角膜厚度自动选择联合不同的切削模式治疗超高度近视具有可预测性、有效性、稳定性及安全性;其中ART模式节省角膜组织有利于薄角膜超高度近视的屈光矫正,但视觉质量值得商榷。     

Posterior corneal ectasia following LASIK

PURPOSE: To evaluate the cases of posterior corneal ectasia following laser in situ keratomileusis. MATERIAL AND METHODS: Thirteen eyes of 7 patients, that were diagnosed to have posterior corneal ectasia (?0.060 mm) on Orbscan topographic system following LASIK, were identified. The parameters evaluated were uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), refraction, contrast sensitivity, glare, corneal topography, keratometry and pachymetry. The preoperative and postoperative data at day 1, 1 week, 1 month, 3 months, 6 months and 1 year were retrospectively analyzed. RESULTS: The mean UCVA of the patients before LASIK surgery was 0.032 +/- 0.04. It was 0.320 +/- 0.159 in follow-up of LASIK surgery after 1 year. The mean Pre-LASIK BCVA was 0.59 +/- 0.11. There was no change in mean BCVA at 1 year. The mean preoperative spherical equivalent was -14.25 +/- 2.91 D except in 2 hyperopic eyes in which the mean spherical equivalent preoperatively was +5.75 +/- 0.35 D. The mean postoperative spherical equivalent after 1 year of LASIK surgery in last follow-up (+/- enhancement) was - 3.45 +/- 2.08 in the myopic eyes and + 1.0 +/- 0.70 in the two hyperopic eyes. The mean preoperative posterior corneal elevation was 0.022 +/- 0.011 mm, which at the end of 1 week following LASIK was 0.067 +/- 0.009 and at 1 year/ last follow-up following LASIK, it was 0.068 +/- 0.006 mm. CONCLUSIONS: Higher amplitudes of refractive correction may lead to the occurrence of posterior corneal ectasia.     

Laser in-situ keratomileusis for refractive error following radial keratotomy

Aim:

To evaluate the safety and efficacy of laser in-situ keratomileusis (LASIK) in eyes with residual/induced refractive error following radial keratotomy (RK).

Design:

Retrospective study.

Materials and Methods:

A retrospective analysis of data of 18 eyes of 10 patients, who had undergone LASIK for refractive error following RK, was performed. All the patients had undergone RK in both eyes at least one year before LASIK. Parameters like uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), contrast sensitivity, glare acuity and corneal parameters were evaluated both preoperatively and postoperatively.

Statistical Software:

STATA-9.0.

Results:

The mean UCVA before LASIK was 0.16±0.16 which improved to 0.64 ± 0.22 (P < 0.001) after one year following LASIK. Fourteen eyes (out of 18) had UCVA of ≥ 20/30 on Snellen''s acuity chart at one year following LASIK. The mean BCVA before LASIK was 0.75 ± 0.18. This improved to 0.87 ± 0.16 at one year following LASIK. The mean spherical refractive error at the time of LASIK and at one year after the procedure was –5.37 ± 4.83 diopters (D) and –0.22 ± 1.45D, respectively. Only three eyes had a residual spherical refractive error of ≥ 1.0D at one year follow-up. In two eyes, we noted opening up of the RK incisions. No eye developed epithelial in-growth till 1 year after LASIK.

Conclusion:

LASIK is effective in treating refractive error following RK. However, it carries the risk of flap-related complications like opening up of the previously placed RK incisions and splitting of the corneal flap.     

Automated lamellar therapeutic keratoplasty (ALTK) in the treatment of anterior to mid-stromal corneal pathologies

PURPOSE: To evaluate the efficacy of automated lamellar therapeutic keratoplasty (ALTK) in the treatment of anterior to mid-stromal corneal pathologies. METHODS: A prospective clinical study was undertaken in 15 eyes of 15 patients who underwent ALTK using the ALTK System (Moria/Microtek Inc., Doylestown, Pennsylvania, USA). The parameters evaluated were uncorrected and best corrected visual acuity (BCVA), keratometry, pachymetry, contrast sensitivity, glare acuity, intraoperative surgical time and complications, postoperative time to epithelialization, graft clarity and postoperative complications. RESULTS: The mean surgical time was 46 +/- 9 mins. The BCVA, contrast sensitivity and glare acuity significantly improved at 6 months postoperatively. The mean decimal BCVA was 0.08 +/- 0.03 preoperatively, which improved to 0.33 +/- 0.30 at 6 months, when 11 eyes had BCVA > or = 6/18. The median epithelialization time was 3 days (range 1-10 days). CONCLUSIONS: Automated lamellar therapeutic keratoplasty appears to be safe and effective for diseases affecting the anterior to mid-stroma of the cornea.     

Laser in situ keratomileusis to correct residual myopia and astigmatism after radial keratotomy

PURPOSE: To evaluate the safety and efficacy of laser in situ keratomileusis (LASIK) in selected post-radial-keratotomy (RK) eyes with residual myopia and astigmatism. SETTING: TLC-The Brea Laser Eye Center, Brea, California, USA. METHODS: Nine eyes of 6 patients who had had RK but had residual myopia and/or astigmatism had LASIK. All RK eyes had 8 radial incisions, were more than 1 year post-RK, had no epithelial inclusion cysts or corneal disease, and had had no subsequent ocular surgery. Follow-up was a minimum of 13 months, at which time uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), manifest refraction, cycloplegic refraction, keratometry, central and peripheral pachymetries, intraocular pressure, and a subjective assessment of visual function were obtained. RESULTS: At the last follow-up, the mean spherical equivalent (SE) was -0.156 diopter (D) +/- 0.174 (SD). All eyes treated for distance vision had a UCVA of 20/25 or better. No patient lost BCVA. No intraoperative or postoperative complications occurred. Seven eyes had morning and evening measurements. The mean change in manifest SE from morning to evening was -0.143 D. Six of the 7 eyes (86%) had 0 to 1 Snellen line change in UCVA from morning to evening. The subjective questionnaire revealed a high degree of satisfaction with overall vision, minimal glare, and less fluctuation in daily vision than before LASIK. CONCLUSION: Laser in situ keratomileusis is safe and efficacious for reducing residual myopia and astigmatism in properly selected RK patients.     

Artisan iris-claw phakic intraocular lens followed by laser in situ keratomileusis for high hyperopia

PURPOSE: To evaluate safety, efficacy, predictability, stability, complications, and patient satisfaction after Artisan phakic intraocular lens (IOL) implantation followed by laser in situ keratomileusis (LASIK) for the correction of high hyperopia. SETTING: Instituto Oftalmólogico de Alicante, Alicante, Spain. METHODS: This prospective trial included 39 eyes with a mean preoperative spherical equivalent (SE) of 7.39 diopters (D) +/- 1.30 (SD) and a cylinder between 0 and -4.25 D. The Artisan iris-fixated phakic IOL (Ophtec) for hyperopia was implanted, and LASIK was performed 6 to 8 months later. The best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), refraction, endothelial cell loss (ECL), endothelium morphologic analysis, and patient satisfaction were recorded. The minimum follow-up was 12 months. RESULTS: At 1 year, 37 eyes (94.9%) were within +/-1.00 D of emmetropia and 31 eyes (79.5%) were within +/-0.50 D. Thirty-five eyes (89.7%) achieved a UCVA of 0.5 or better. There was a statistically significant decrease in BCVA after phakic IOL implantation, but this effect was corrected after LASIK. Nine eyes (23.1%) lost 1 line of BCVA; 7 eyes (17.9%) gained at least 1 line. One eye (2.6%) showed a change in SE greater than 1.0 D over the follow-up period. The mean ECL was 10.9%, but morphologic analysis suggested no additional damage caused by LASIK over that produced by phakic IOL surgery. Overall patient satisfaction was high. CONCLUSIONS: The combination of Artisan phakic IOL implantation and LASIK safely, predictably, and effectively reduced high hyperopia. A loss of 1 line of BCVA should be expected in about one third of eyes implanted with this IOL. Halos and glare at night remain a potential problem.     

Wavefront- and topography-guided ablation in myopic eyes using Zyoptix

PURPOSE: To evaluate the results of wavefront- and topography-guided ablation in myopic eyes using Zyoptix (Bausch & Lomb). SETTING: Eye Research Center and Dr. Agarwal's Eye Hospital, Chennai, India. METHODS: This observational case study comprised 150 eyes with myopia and compound myopic astigmatism. Preoperatively, the patients had corneal topography with Orbscan IIz (Bausch & Lomb) and wavefront analysis with the Zywave aberrometer (Bausch & Lomb) in addition to the routine workup before laser in situ keratomileusis (LASIK). The results were assimilated using Zylink software (Bausch & Lomb), and a customized treatment plan was formulated. Laser in situ keratomileusis was performed with the Technolas 217 system (Bausch & Lomb). The patients were followed for at least 6 months. RESULTS: The mean preoperative best corrected visual acuity (BCVA) (in decimal equivalent) was 0.83 (20/25) +/- 0.18 (SD) (range 0.33 to 1.00) and the mean postoperative (6 months) BCVA, 1.00 (20/20) +/- 0.23 (range 0.33 to 1.50). Three eyes (2%) lost 2 or more lines of best spectacle-corrected visual acuity. The safety index was 1.20. The mean preoperative uncorrected visual acuity (UCVA) was 0.06 (20/350) +/- 0.02 (range 0.01 to 0.50) and the mean postoperative UCVA, 0.88 (20/25) +/- 0.36 (range 0.08 to 1.50). The efficacy index was 14.66. The mean preoperative spherical equivalent (SE) was -5.25 +/- 1.68 diopters (D) (range -0.87 to -15.00 D) and the mean postoperative SE (6 months), -0.36 +/- 0.931 D (range -4.25 to +1.25 D). At 6 months, the UCVA was 1.00 (6/6) or better in 105 eyes (69.93%) and 0.5 (6/12) or better in 126 eyes (83.91%). The postoperative aberrations were decreased compared with the preoperative aberrations. One eye (0.66%) had a free cap during LASIK with subsequent loss of 2 lines of BCVA and induced higher-order aberrations (HOAs). Nine patients (11.2%) complained of halos at night. CONCLUSIONS: Wavefront- and topography-guided LASIK leads to improve visual performance by decreasing HOAs. Scotopic visual complaints may be reduced with this method.     

Glare and halo phenomena after laser in situ keratomileusis

PURPOSE: To simulate and measure subjectively observed glare and halos after laser in situ keratomileusis (LASIK). SETTING: University of Vienna, Medical School, Department of Ophthalmology, Vienna, Austria. METHODS: In 16 eyes of 10 patients, the best corrected visual acuity (BCVA) and subjectively observed glare and halo size under mesopic conditions were measured before LASIK and 1, 3, and 6 months postoperatively. Infrared pupillography was used to ensure that all patients had a larger ablation zone than the measured pupil size under mesopic conditions. RESULTS: Preoperatively, the mean Snellen BCVA was 0.88 +/- 0.17 (SD) and the mean glare and halo size was 1.97 +/- 1.20 square degrees (sqd) before the treatment. One month after LASIK, the BCVA was 0.83 +/- 0.29 and the mean glare and halo size, 2.61 +/- 3.14 sqd. Three months after LASIK, the mean values were 0.90 +/- 0.26 and 1.88 +/- 2.37 sqd, respectively. Six months after LASIK treatment, they were 0.85 +/- 0.28 and 1.30 +/- 1.63 sqd, respectively. The 95% confidence interval for the difference between preoperative glare and halo and glare and halo at 6 months was -1.56 to + 0.51 sqd. CONCLUSIONS: Subjectively observed glare and halo size after LASIK reached a peak after 1 month and decreased in the following postoperative period.     

Effect of expanding the treatment zone of the Nidek EC-5000 laser on laser in situ keratomileusis outcomes

PURPOSE: To evaluate the effect of expanding the treatment zone of the Nidek EC-5000 laser on postoperative visual acuity as well as night glare and halos after laser in situ keratomileusis (LASIK) using 4 ablation zone diameters. SETTING: Division of Ophthalmology, Evanston Northwestern Healthcare and Northwestern University Medical School, Glenview, Illinois, USA. METHODS: This prospective study comprised 301 eyes of 154 consecutive patients who had LASIK in 1 or both eyes using the Nidek EC-5000 laser by 1 surgeon with experience in keratomileusis and excimer laser refractive surgery. A 6.5 mm optical zone was used with a transition zone 1.0 mm larger than the pupil under scotopic conditions (7.5, 8.0, 8.5, or 9.0 mm). Targeted correction was calculated according to a customized clinical nomogram. All patients were queried about glare and halos preoperatively and 3 months postoperatively using a questionnaire assigning numeric values to the degree of perceived visual disturbance (0 = no glare or halos, 1 = minimal, 2 = moderate, 3 = severe). RESULTS: The baseline uncorrected visual acuity (UCVA) was 20/200 or worse in 293 eyes. The baseline best spectacle-corrected visual acuity was 20/20 or better. The mean preoperative refractive sphere was -6.33 diopters (D) +/- 2.80 (SD) (range -1.00 to -16.25 D) and the mean preoperative refractive cylinder, 0.86 +/- 0.83 D (range 0 to +3.25 D). Three months postoperatively, 78% of eyes had a UCVA of 20/20 and 99%, of 20/40 or better. Preoperatively, 94 eyes (31%) had glare and halos. At 3 months, glare, halos, or both were present in 19 eyes of 11 patients (6.3%) (P<.0001); in 14 eyes, patients reported less severe glare and halos postoperatively than preoperatively. CONCLUSIONS: The use of a peripheral transition zone 1.0 mm larger than the pupil under scotopic conditions resulted in a low incidence of glare and halos postoperatively and did not adversely affect visual acuity. There was no increase in postoperative complications including corneal ectasia.     

Comparison of higher-order aberrations after wavefront-guided laser in situ keratomileusis and laser-assisted subepithelial keratectomy

PURPOSE: To compare the higher-order aberrations (HOAs) in 70 eyes (38 patients) that had wavefront-guided laser in situ keratomileusis (LASIK) with those in 70 eyes (40 patients) that had wavefront-guided laser-assisted subepithelial keratectomy (LASEK) for the treatment of myopia. SETTING: Department of Ophthalmology, Yonsei University College of Medicine, Myongdong Bal-geun sesang Eye Clinic, and Seran Eye Center, Seoul, Korea. METHODS: In a prospective study, 140 consecutive eyes of 78 patients were treated with wavefront-guided LASIK or LASEK according to the patient's choice after each procedure had been thoroughly explained. The patients were followed for 6 months. Best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), manifest refraction, and wavefront aberrations were measured at baseline and 1, 3, and 6 months after surgery. RESULTS: There were no significant differences in postoperative BCVA, UCVA, and manifest refraction between groups. The mean root-mean-square wavefront error of HOAs for a scotopic pupil in the wavefront-guided LASIK group was significantly smaller than that in the wavefront-guided LASEK group at 1 month. Analyzing individual Zernike coefficients, the spherical aberration and second coma were significantly smaller in the wavefront-guided LASIK group than in the wavefront-guided LASEK group at 1 month. This difference in HOAs between groups disappeared at 3 and 6 months. CONCLUSIONS: The HOAs in the scotopic condition were not different between the wavefront-guided LASIK and LASEK groups beginning 3 months after surgery. However, the HOAs in the LASIK and LASEK groups had a different time course, especially in the case of spherical aberration. This finding suggests that postoperative changes in aberration contribute to the final outcome of wavefront-guided ablation.     

Bitoric laser in situ keratomileusis for astigmatism

PURPOSE: To evaluate the efficacy, predictability, and safety of bitoric laser in situ keratomileusis (LASIK) for the correction of mixed astigmatism. SETTING: Instituto Oftalmológico de Alicante, Alicante, Spain. METHODS: This prospective study included 28 eyes of 21 patients with mixed astigmatism who had bitoric LASIK using the Hansatome microkeratome (Bausch & Lomb Surgical) and the Chiron Technolas 217 excimer laser (Bausch & Lomb Surgical). The main outcome measures were uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), defocus equivalent, blur strength, and refraction. RESULTS: Six months after bitoric LASIK, the mean UCVA was 0.70 +/- 0.23 (SD). The percentage of eyes with a UCVA of 20/40 or better was 78.6% and of 20/20, 21.4%. There was a statistically significant increase in the mean BCVA from 0.71 +/- 0.19 before surgery to 0.83 +/- 0.15 at 6 months (P =.0004). Three eyes (10.7%) lost 1 line of BCVA; 19 eyes (67.9%) gained 1 or more lines. The mean preoperative astigmatism of -4.04 +/- 1.13 diopters (D) was reduced to -0.67 +/- 0.79 D after surgery. The defocus equivalent was less than 1.00 D in 75.0% of eyes and less than 0.50 D in 64.3%. Vector analysis showed that the mean achieved correction was 97.4% of the intended correction. CONCLUSIONS: Bitoric LASIK was a safe, effective, and predictable procedure in the treatment of mixed astigmatism. It is a means to improving BCVA in a significant percentage of patients.     

LASIK术中两种复瓣法的疗效比较

目的:探讨LASIK术中单纯粗大水流复瓣与粗大水流联合吸血海绵复瓣的疗效。方法:收集2011-07/08就诊于我院行LASIK手术的211例418眼患者,按就诊先后顺序将患者随机分为2组,第一组105例208眼患者给予单纯粗大水流复瓣,第二组106例210眼患者给予粗大水流与吸血海绵联合复瓣,观察术后1d,1wk,1mo患者角膜瓣复位情况、最佳矫正视力及患者有无眩光不适等情况。结果:两组患者术后1d,1wk,1mo角膜均无明显错位及皱褶,术后第1d第一组3眼出现龟背纹,第二组2眼出现龟背纹,采用Fisher确切概率法,差异无统计学意义（P＞0.05）。两组患者术后1d视力分别为1.07±0.11,1.10±0.18,经独立样本t检验,差异无统计学意义（P＞0.05）。术后裸眼视力均达术前最佳矫正视力,且两组患者均未出现眩光等不适。结论:LASIK术中单纯粗大水流复瓣与粗大水流联合吸血海绵复瓣所达到的术后疗效等同。     

Long term analysis of LASIK for the correction of refractive errors after penetrating keratoplasty

PURPOSE: To determine the long-term safety and effectiveness of laser in-situ keratomileusis (LASIK) in the treatment of refractive errors following penetrating keratoplasty (PK). METHODS: A retrospective review was performed of 57 eyes of 48 patients with anisometropia or high astigmatism who were unable to wear glasses or a contact lens after PK and who underwent LASIK for visual rehabilitation. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BCVA), and corneal transplant integrity were recorded before surgery as well as up to 60 months after LASIK. RESULTS: The mean follow-up after the LASIK was 21.4 +/- 14.2 months (range 3 to 60 months). Mean preoperative spherical equivalent (SE) was -4.19 +/- 3.38 D. The mean preoperative astigmatism was 4.67 +/- 2.18 D. Preoperative BCVA was 20/40 or better in 42 eyes (74%). At 2 years the mean SE was -0.61 +/- 1.81 D, and mean astigmatism was 1.94 +/- 1.35 D for the 28 eyes with follow-up. UCVA was 20/40 or better in 12 eyes (43%), and BCVA was 20/40 or better in 24 eyes (86%) at 2 years. A gain in BCVA of 1 line or more was seen in 8 eyes (29%). Two eyes (7%) had loss of 2 or more lines of BCVA at 2 years. There were 9 eyes (16%) that developed epithelial ingrowth. Five eyes (9%) in this series had repeat corneal transplants. CONCLUSIONS: LASIK is effective for reducing ametropia after PK. Proper patient counseling is necessary because the results of LASIK after PK are not as good as, and complications are more frequent than in eyes with naturally occurring myopia and astigmatism. Complications are especially common in patients with mismatch of the donor and host cornea or in those with poor endothelial cell function.     

准分子激光原位角膜磨镶术和准分子激光上皮下磨镶术矫正高度近视的视觉质量对比研究

目的 从视觉质量的角度评价准分子激光原位角膜磨镶术（LASIK）和准分子激光上皮下磨镶术（LASEK）矫正高度近视的疗效。方法对34人（68眼）进行LASIK或LASEK手术的高度近视患者（其中LASEK19人38眼，LASIK组15人30眼）术前，术后1月和术后3月时评价视觉质量，包括术后裸眼视力（UCVA），最佳矫正视组（BCVA组），对比敏感度，眩光和波前像差。结果 LASEK组UCVA提高较LASIK组慢。LASEK和LASIK的术后IN2VA无差异。LASEK组术后的对比敏感度无下降；眩光在术后1月时下降，术后3月时恢复至术前水平。LASIK组术后1月时对比敏感度和眩光均明显下降，术后3月时对比敏感度恢复但眩光仍未恢复至术前水平。LASEK组和LASIK组术后1月和3月的高阶像差RMS均较术前大，但前者比后者小。LASEK组有一定的haze发生，但程度轻。结论 LASEK矫正高度近视能获得更好的视觉质量，关键在于如何更好的保留上皮瓣的活力。     

LASIK after retinal detachment surgery

PURPOSE: To compare, in the same individuals, the safety and efficacy of laser in situ keratomileusis (LASIK) in eyes with and without previous retinal detachment surgery. METHODS: In a prospective clinical trial, seven myopic patients who had previously undergone scleral buckling surgery in one eye underwent conventional LASIK surgery in both eyes. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), refraction, Orbscan topography and pachymetry were recorded before and 1, 3, 6 and 12 months after surgery. The eyes were divided into two groups: group 1 consisted of eyes that had undergone previous surgery for retinal detachment, and group 2 consisted of the fellow eyes of the same patients, which had not undergone any previous ocular surgery. Student's t-test for match-paired data was used to evaluate the significance of differences. RESULTS: LASIK was performed successfully in all patients. The UCVA improved in all eyes in both groups. The mean change in the spherical equivalent between 1 and 12 months after LASIK surgery was 1.7 +/- 1.1 and 0.6 +/- 0.5 diopter in groups 1 and 2, respectively (p = 0.019). CONCLUSION: LASIK may be considered for treatment of myopia in eyes that have had previous surgery for retinal detachment. However, the risk of regression may be higher in such eyes than in eyes with no previous scleral buckling surgery.     

激光性角膜手术与眼内屈光手术矫治超高度近视眼

目的:评价及探讨矫治超高度近视眼的各类屈光手术的有效性、稳定性和安全性。方法:随机选择临床中观察到的超高度近视患者行各类屈光手术者108眼,近视范围-10.00～-24.50D,术前屈光度平均为(-12.25±1.53)D,散光平均为(-1.52±0.55)D;手术方式的选择:(1)I组52眼,行LASIK术:(2)II组23眼,行透明晶状体超声乳化摘除加后房型人工晶状体植入术。(3)III组33眼行有晶状体眼虹膜固定型人工晶状体植入术。术后随访观察平均6mo,主要观察术后裸眼视力、最佳矫正视力、屈光度、眼压及眼前段、眼底情况。结果:三组术后裸眼视力均比术前提高,术后裸眼视力≥0.5者分别是42眼(80.8%),20眼(87.0%),28眼(84.8%),术后屈光度分别为(-2.10±2.38)D,(-1.75±1.33)D,(0.83±1.16)D,主要并发症I组术后6mo黄斑出血1眼,II组术后15mo视网膜脱离1眼,III组平均角膜内皮细胞丢失率为4.5%。结论:对于超高度近视,晶状体性屈光手术效果优于LASIK术。对超高度近视行屈光手术,要根据患者年龄,眼部情况,手术医师的技术等,选择安全、有效、稳定性好的手术。     

中老年高度近视眼透明晶状体摘除人工晶状体植入术与LASIK术的疗效比较

目的比较和评价透明晶状体摘除联合人工晶状体(intraocular len,IOL)植入术和准分子激光原位角膜磨镶术(laser in situ keratomileusis,LASIK)治疗中、老年高度近视患者的临床效果。方法 93例(179只眼)高度近视患者分为两组:A组透明晶状体摘除折叠人工晶状体植入术组45例(86只眼),B组LASIK手术组48例(93 只眼)。观察术前及术后1周裸眼视力、术后3个月远近视力的屈光状态及手术并发症。结果术后1周两组的裸眼远视力都比术前有明显增加,但A组远视力增加明显高于B组,术后3个月A组矫正远视力的球镜度、柱镜度明显低于B组,但A组矫正近视力球镜度却高于B组,差异有高度显著性。术后B组屈光回退率高于A组,A组4 只眼发生晶状体后囊膜混浊,两组无其他严重的并发症发生。结论对中、老年高度近视患者行透明晶状体摘除折叠人工晶状体植入术具有安全、有效等优点,具有比LASIK更令人满意的视觉效果。     

Hyperopic LASIK with Esiris/Schwind technology

PURPOSE: To investigate the refractive and visual outcomes of hyperopic LASIK using Esiris/Schwind technology. METHODS: This retrospective non-comparative observational study included 106 eyes (65 patients) operated with the Esiris/Schwind laser for hyperopia. Eyes were divided into two groups: group 1, < or = +3.99 diopters (D) and group 2, > or = +4.0 D (up to +7.0 D). Visual outcome for distance and near uncorrected (UCVA) and best spectacle-corrected visual acuities (BSCVA) (decimal values), cycloplegic refraction, keratometry (K), pachymetry, and complications were evaluated. RESULTS: In group 1, mean UCVA was 0.4 +/- 0.1 preoperatively and 0.8 +/- 0.2 6 months postoperatively. Mean BSCVA was 0.9 +/- 0.1 preoperatively and 0.9 +/- 0.1 6 months postoperatively. Safety index was 1.1 and efficacy index was 0.97. Mean spherical equivalent refraction was +2.33 +/- 0.9 D preoperatively and +0.3 +/- 0.3 D 6 months postoperatively. Mean K reading was 43.7 +/- 1.1 D preoperatively and 45.0 +/- 1.6 D 6 months postoperatively. In group 2, mean UCVA was 0.3 +/- 0.1 preoperatively and 0.8 +/- 0.2 6 months postoperatively. Mean BSCVA was 0.9 +/- 0.1 preoperatively and 0.9 +/- 0.1 6 months postoperatively. Safety index was 0.98 and efficacy index was 0.92. Mean spherical equivalent refraction was +5.1 +/- 0.9 D preoperatively and +0.4 +/- 0.5 D 6 months postoperatively. Mean K reading was 43.1 +/- 1.6 D preoperatively and 46.0 +/- 1.4 D 6 months postoperatively. Forty-six (90.2%) of 51 eyes in group 1 and 47 (85.5%) of 55 eyes in group 2 were within +/- 0.5 D of emmetropia. At 6-month follow-up, 40 (78%) of 51 eyes in group 1 had UCVA of 20/20 compared to 41 (75%) of 51 eyes in group 2. One (2%) of 51 eyes in group 1 and 4 (7.3%) of 55 eyes in group 2 lost < or = 2 lines of BSCVA. No eye lost >2 lines of BSCVA. CONCLUSIONS: Hyperopic LASIK with Esiris/Schwind technology is effective and safe in the correction of hyperopia up to + 7.0 D. Although a slight statistical significance was found for low hyperopia, visual and refractive results obtained in high hyperopia were encouraging.     

二次LASIK行角膜瓣背面基质切削的临床观察

目的 探讨行角膜瓣背面基质切削治疗准分子激光原位角膜磨镶术(laserin situkeratomileusis,LASIK)后屈光回退或欠矫且角膜基质床厚度不足的患者的安全性和有效性.方法 对9例(16只眼)LASIK术后有屈光回退或欠矫的患者,根据其残余屈光度和角膜瓣厚度行角膜瓣背面基质切削术.屈光欠矫范围为-1.00～-2.25D,平均(-1.45±0.34)D.结果 所有眼术后裸眼视力均好于术前,无最佳矫正视力下降,术后屈光度较术前明显下降;6个月时均获得0.8以上视力,屈光度≤±0.5 D者占72%,±1.0D者为100%.无角膜瓣移位、皱褶、上皮植入、角膜膨隆等并发症.结论 角膜瓣背面基质切削作为一种补充治疗LASIK术后屈光欠矫且角膜基质床厚度不足效果好,安全性强.